rAAV Cis-Elements for Packaging Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinantly-modified adeno-associated virus (rAAV) face limitations in packaging efficiency due to dependence on helper viruses and insufficient understanding of replication factors, leading to suboptimal production titers.
Innovation Solution
Incorporation of Cis-Elements, such as replication origins, promoters, and enhancers, within specific domains of the rAAV genome, including potential or actual G-Quadruplex Sequences, to regulate rAAV replication and improve packaging efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional rAAV production methods are used, then the production process is simple, but the packaging efficiency and production titer are suboptimal
Solution Approach 1:
The patent applies preliminary action by incorporating Cis-Elements (replication origins, promoters, enhancers) into the rAAV genome before production. These elements are pre-configured to regulate replication and enhance packaging efficiency, allowing the system to achieve higher production titers without complicating the production process itself. The Cis-Elements are integrated into specific domains (P1-P4) flanking the ITR sequences, creating a ready-to-use genome structure that automatically improves packaging when produced.
2Productivity
If helper viruses are used for rAAV production, then viral replication functions are provided, but packaging efficiency is limited by dependence on helper viruses
Solution Approach 1:
The patent implements self-service by enabling the rAAV genome to regulate its own replication through integrated Cis-Elements. The replication origins, promoters, and enhancers within the P1-P4 domains allow the genome to autonomously control replication processes, reducing dependence on external helper viruses. The G-Quadruplex sequences specifically enhance replication efficiency by forming stable structures that facilitate origin recognition and replication initiation, allowing the system to partially self-regulate packaging efficiency.
3Productivity
If G-Quadruplex Sequences are incorporated, then replication regulation is enhanced, but the genome sequence complexity increases
Solution Approach 1:
The patent applies local quality by strategically placing G-Quadruplex sequences and other Cis-Elements only in specific domains (P1, P2, P3, or P4) that flank the ITR sequences, rather than throughout the entire genome. This localized approach enhances replication efficiency at critical regulatory points while minimizing overall genome complexity. The G-Quadruplex structures are positioned to specifically facilitate origin recognition and replication initiation without affecting other genomic regions.
Data Source
AI summary
The present invention is directed to recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency, pharmaceutical compositions comprising such rAAV, and methods for their production and use. The present invention is particularly directed to recombinantly-modified adeno-associated virus (rAAV) that have been further modified to comprise Cis-Elements, including replication origins, promoters and enhancers, that are capable of regulating the replication of an rAAV genome and that improve rAAV replication. Preferably, such Cis-Elements are provided within domains of the rAAV that precede and/or follow the 5′ and/or 3′ inverted terminal repeated sequences (ITR) of an rAAV. The invention particularly concerns the presence and the use of polynucleotide Cis-Elements that comprise actual or potential G-Quadruplex Sequences, polynucleotide Cis-Elements that comprise DNA sequences from wild-type AAV (wt AAV) and polynucleotide Cis-Elements that comprise DNA sequences from other viral genomes or from the human genome.